# FDA Inspection 1260563 - Adnan H. Siddiqui, M.D. - January 27, 2025

Source: https://www.keypedia.com/records/fda_inspections/adnan-h-siddiqui-md/d0f7d802-1078-44ee-9e5b-86da5ddd0fc1
Source feed: FDA_Inspections

> FDA Inspection 1260563 for Adnan H. Siddiqui, M.D. on January 27, 2025. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1260563
- Company Name: Adnan H. Siddiqui, M.D.
- Inspection Date: 2025-01-27
- Classification: No Action Indicated (NAI)
- Project Area: Bioresearch Monitoring
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 1023789 - 2017-08-01](https://www.keypedia.com/records/fda_inspections/adnan-h-siddiqui-md/2c3d8858-a3ae-4dec-8a8b-b2934c815a58)
- [FDA Inspection 915443 - 2015-02-24](https://www.keypedia.com/records/fda_inspections/adnan-h-siddiqui-md/262360d6-f645-4788-aa87-1925dc2c120e)

Company: https://www.keypedia.com/companies/adnan-h-siddiqui-md/add66b13-2a60-46a7-8b92-dbaf34a45330

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c
